nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP2C9—brain cancer	0.561	1	CbGaD
Clopidogrel—CYP1A2—Carmustine—brain cancer	0.0621	0.257	CbGbCtD
Clopidogrel—CYP3A4—Temozolomide—brain cancer	0.0469	0.194	CbGbCtD
Clopidogrel—CYP3A4—Lomustine—brain cancer	0.0399	0.165	CbGbCtD
Clopidogrel—CYP3A5—Etoposide—brain cancer	0.0247	0.102	CbGbCtD
Clopidogrel—CYP2C8—Etoposide—brain cancer	0.0238	0.0984	CbGbCtD
Clopidogrel—CYP1A2—Etoposide—brain cancer	0.0184	0.0762	CbGbCtD
Clopidogrel—ABCB1—Etoposide—brain cancer	0.0161	0.0666	CbGbCtD
Clopidogrel—CYP3A4—Etoposide—brain cancer	0.00965	0.0399	CbGbCtD
Clopidogrel—CES1—Phase I biotransformations, non P450—PON1—brain cancer	0.00744	0.125	CbGpPWpGaD
Clopidogrel—Prasugrel—CYP2C9—brain cancer	0.00342	0.545	CrCbGaD
Clopidogrel—Ticlopidine—CYP2C9—brain cancer	0.00285	0.455	CrCbGaD
Clopidogrel—CES1—E2F transcription factor network—HIC1—brain cancer	0.00215	0.0361	CbGpPWpGaD
Clopidogrel—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00198	0.0333	CbGpPWpGaD
Clopidogrel—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00178	0.0299	CbGpPWpGaD
Clopidogrel—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00163	0.0274	CbGpPWpGaD
Clopidogrel—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00162	0.0272	CbGpPWpGaD
Clopidogrel—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00159	0.0267	CbGpPWpGaD
Clopidogrel—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00145	0.0243	CbGpPWpGaD
Clopidogrel—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00138	0.0232	CbGpPWpGaD
Clopidogrel—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00124	0.0208	CbGpPWpGaD
Clopidogrel—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00123	0.0207	CbGpPWpGaD
Clopidogrel—CES1—Irinotecan Pathway—APC—brain cancer	0.00123	0.0206	CbGpPWpGaD
Clopidogrel—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00113	0.0189	CbGpPWpGaD
Clopidogrel—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00101	0.017	CbGpPWpGaD
Clopidogrel—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000988	0.0166	CbGpPWpGaD
Clopidogrel—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00095	0.0159	CbGpPWpGaD
Clopidogrel—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000856	0.0144	CbGpPWpGaD
Clopidogrel—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000823	0.0138	CbGpPWpGaD
Clopidogrel—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000764	0.0128	CbGpPWpGaD
Clopidogrel—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000734	0.0123	CbGpPWpGaD
Clopidogrel—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000694	0.0116	CbGpPWpGaD
Clopidogrel—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000678	0.0114	CbGpPWpGaD
Clopidogrel—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000661	0.0111	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000631	0.0106	CbGpPWpGaD
Clopidogrel—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000595	0.00999	CbGpPWpGaD
Clopidogrel—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000572	0.0096	CbGpPWpGaD
Clopidogrel—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000524	0.0088	CbGpPWpGaD
Clopidogrel—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000512	0.00859	CbGpPWpGaD
Clopidogrel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000488	0.00818	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—SIRT1—brain cancer	0.00046	0.00772	CbGpPWpGaD
Clopidogrel—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000459	0.00771	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—CCNE1—brain cancer	0.000455	0.00763	CbGpPWpGaD
Clopidogrel—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000442	0.00741	CbGpPWpGaD
Clopidogrel—Body temperature increased—Lomustine—brain cancer	0.000433	0.00329	CcSEcCtD
Clopidogrel—Oesophagitis—Etoposide—brain cancer	0.000431	0.00328	CcSEcCtD
Clopidogrel—Rash maculo-papular—Etoposide—brain cancer	0.000428	0.00326	CcSEcCtD
Clopidogrel—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00042	0.00704	CbGpPWpGaD
Clopidogrel—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000414	0.00695	CbGpPWpGaD
Clopidogrel—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000414	0.00315	CcSEcCtD
Clopidogrel—Stomatitis—Hydroxyurea—brain cancer	0.000411	0.00313	CcSEcCtD
Clopidogrel—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000411	0.0069	CbGpPWpGaD
Clopidogrel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00041	0.00688	CbGpPWpGaD
Clopidogrel—Liver function test abnormal—Carmustine—brain cancer	0.000409	0.00311	CcSEcCtD
Clopidogrel—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000405	0.00679	CbGpPWpGaD
Clopidogrel—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000399	0.00303	CcSEcCtD
Clopidogrel—Anaemia—Procarbazine—brain cancer	0.000394	0.00299	CcSEcCtD
Clopidogrel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000389	0.00653	CbGpPWpGaD
Clopidogrel—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000385	0.00293	CcSEcCtD
Clopidogrel—Syncope—Procarbazine—brain cancer	0.000382	0.00291	CcSEcCtD
Clopidogrel—Leukopenia—Procarbazine—brain cancer	0.000381	0.0029	CcSEcCtD
Clopidogrel—Haemoglobin—Hydroxyurea—brain cancer	0.000381	0.00289	CcSEcCtD
Clopidogrel—Haemorrhage—Hydroxyurea—brain cancer	0.000379	0.00288	CcSEcCtD
Clopidogrel—Hallucination—Hydroxyurea—brain cancer	0.000377	0.00287	CcSEcCtD
Clopidogrel—Loss of consciousness—Procarbazine—brain cancer	0.000374	0.00285	CcSEcCtD
Clopidogrel—Abdominal distension—Temozolomide—brain cancer	0.000372	0.00283	CcSEcCtD
Clopidogrel—Cough—Procarbazine—brain cancer	0.000372	0.00283	CcSEcCtD
Clopidogrel—Hypertension—Procarbazine—brain cancer	0.000368	0.0028	CcSEcCtD
Clopidogrel—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000367	0.00616	CbGpPWpGaD
Clopidogrel—Pancytopenia—Carmustine—brain cancer	0.000363	0.00276	CcSEcCtD
Clopidogrel—Myalgia—Procarbazine—brain cancer	0.000363	0.00276	CcSEcCtD
Clopidogrel—Arthralgia—Procarbazine—brain cancer	0.000363	0.00276	CcSEcCtD
Clopidogrel—Anxiety—Procarbazine—brain cancer	0.000361	0.00275	CcSEcCtD
Clopidogrel—Neutropenia—Carmustine—brain cancer	0.000358	0.00272	CcSEcCtD
Clopidogrel—Bronchitis—Temozolomide—brain cancer	0.000355	0.0027	CcSEcCtD
Clopidogrel—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000355	0.00596	CbGpPWpGaD
Clopidogrel—Anaphylactoid reaction—Etoposide—brain cancer	0.000354	0.00269	CcSEcCtD
Clopidogrel—Pancytopenia—Temozolomide—brain cancer	0.000351	0.00267	CcSEcCtD
Clopidogrel—Cardiac failure—Etoposide—brain cancer	0.000351	0.00267	CcSEcCtD
Clopidogrel—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000351	0.00588	CbGpPWpGaD
Clopidogrel—Confusional state—Procarbazine—brain cancer	0.000351	0.00267	CcSEcCtD
Clopidogrel—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000348	0.00585	CbGpPWpGaD
Clopidogrel—Vomiting—Lomustine—brain cancer	0.000348	0.00265	CcSEcCtD
Clopidogrel—Oedema—Procarbazine—brain cancer	0.000348	0.00264	CcSEcCtD
Clopidogrel—Neutropenia—Temozolomide—brain cancer	0.000346	0.00263	CcSEcCtD
Clopidogrel—Infection—Procarbazine—brain cancer	0.000345	0.00263	CcSEcCtD
Clopidogrel—Angiopathy—Hydroxyurea—brain cancer	0.000344	0.00261	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Temozolomide—brain cancer	0.000344	0.00261	CcSEcCtD
Clopidogrel—Pneumonia—Carmustine—brain cancer	0.000343	0.00261	CcSEcCtD
Clopidogrel—Shock—Procarbazine—brain cancer	0.000342	0.0026	CcSEcCtD
Clopidogrel—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00034	0.00571	CbGpPWpGaD
Clopidogrel—Depression—Carmustine—brain cancer	0.00034	0.00259	CcSEcCtD
Clopidogrel—Renal failure—Carmustine—brain cancer	0.000335	0.00255	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Carmustine—brain cancer	0.000334	0.00254	CcSEcCtD
Clopidogrel—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000333	0.00558	CbGpPWpGaD
Clopidogrel—Stomatitis—Carmustine—brain cancer	0.000332	0.00253	CcSEcCtD
Clopidogrel—Urinary tract infection—Carmustine—brain cancer	0.000331	0.00252	CcSEcCtD
Clopidogrel—Pneumonia—Temozolomide—brain cancer	0.000331	0.00252	CcSEcCtD
Clopidogrel—Depression—Temozolomide—brain cancer	0.000329	0.0025	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000327	0.00248	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—MPL—brain cancer	0.000325	0.00546	CbGpPWpGaD
Clopidogrel—Nausea—Lomustine—brain cancer	0.000325	0.00247	CcSEcCtD
Clopidogrel—Hypotension—Procarbazine—brain cancer	0.000325	0.00247	CcSEcCtD
Clopidogrel—P2RY12—GPCR ligand binding—PTCH2—brain cancer	0.000324	0.00544	CbGpPWpGaD
Clopidogrel—Neuropathy peripheral—Temozolomide—brain cancer	0.000323	0.00246	CcSEcCtD
Clopidogrel—Stomatitis—Temozolomide—brain cancer	0.000321	0.00244	CcSEcCtD
Clopidogrel—Urinary tract infection—Temozolomide—brain cancer	0.00032	0.00244	CcSEcCtD
Clopidogrel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000317	0.00532	CbGpPWpGaD
Clopidogrel—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000317	0.00241	CcSEcCtD
Clopidogrel—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000315	0.00529	CbGpPWpGaD
Clopidogrel—Insomnia—Procarbazine—brain cancer	0.000314	0.00239	CcSEcCtD
Clopidogrel—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000313	0.00525	CbGpPWpGaD
Clopidogrel—Paraesthesia—Procarbazine—brain cancer	0.000312	0.00237	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—S100A10—brain cancer	0.000312	0.00524	CbGpPWpGaD
Clopidogrel—Hepatobiliary disease—Temozolomide—brain cancer	0.000312	0.00237	CcSEcCtD
Clopidogrel—Sinusitis—Temozolomide—brain cancer	0.000309	0.00235	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000308	0.00234	CcSEcCtD
Clopidogrel—Haemoglobin—Carmustine—brain cancer	0.000308	0.00234	CcSEcCtD
Clopidogrel—Haemorrhage—Carmustine—brain cancer	0.000306	0.00233	CcSEcCtD
Clopidogrel—Anaemia—Hydroxyurea—brain cancer	0.000305	0.00232	CcSEcCtD
Clopidogrel—Hallucination—Carmustine—brain cancer	0.000305	0.00232	CcSEcCtD
Clopidogrel—Hypoaesthesia—Carmustine—brain cancer	0.000305	0.00232	CcSEcCtD
Clopidogrel—Oedema peripheral—Carmustine—brain cancer	0.000302	0.00229	CcSEcCtD
Clopidogrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.0003	0.00504	CbGpPWpGaD
Clopidogrel—Fatigue—Procarbazine—brain cancer	0.0003	0.00228	CcSEcCtD
Clopidogrel—Haemoglobin—Temozolomide—brain cancer	0.000297	0.00226	CcSEcCtD
Clopidogrel—Constipation—Procarbazine—brain cancer	0.000297	0.00226	CcSEcCtD
Clopidogrel—Pain—Procarbazine—brain cancer	0.000297	0.00226	CcSEcCtD
Clopidogrel—Hepatitis—Temozolomide—brain cancer	0.000296	0.00225	CcSEcCtD
Clopidogrel—Haemorrhage—Temozolomide—brain cancer	0.000296	0.00225	CcSEcCtD
Clopidogrel—Leukopenia—Hydroxyurea—brain cancer	0.000295	0.00224	CcSEcCtD
Clopidogrel—Visual impairment—Carmustine—brain cancer	0.000295	0.00224	CcSEcCtD
Clopidogrel—Hypoaesthesia—Temozolomide—brain cancer	0.000294	0.00224	CcSEcCtD
Clopidogrel—Hallucination—Temozolomide—brain cancer	0.000294	0.00224	CcSEcCtD
Clopidogrel—Urinary tract disorder—Temozolomide—brain cancer	0.000292	0.00222	CcSEcCtD
Clopidogrel—Oedema peripheral—Temozolomide—brain cancer	0.000291	0.00222	CcSEcCtD
Clopidogrel—Bronchospasm—Etoposide—brain cancer	0.000291	0.00221	CcSEcCtD
Clopidogrel—Urethral disorder—Temozolomide—brain cancer	0.00029	0.00221	CcSEcCtD
Clopidogrel—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000288	0.00483	CbGpPWpGaD
Clopidogrel—Feeling abnormal—Procarbazine—brain cancer	0.000286	0.00218	CcSEcCtD
Clopidogrel—Eye disorder—Carmustine—brain cancer	0.000286	0.00218	CcSEcCtD
Clopidogrel—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000286	0.0048	CbGpPWpGaD
Clopidogrel—Visual impairment—Temozolomide—brain cancer	0.000285	0.00217	CcSEcCtD
Clopidogrel—P2RY12—GPCR downstream signaling—OR4C12—brain cancer	0.000284	0.00477	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—OR14C36—brain cancer	0.000284	0.00477	CbGpPWpGaD
Clopidogrel—Gastrointestinal pain—Procarbazine—brain cancer	0.000284	0.00216	CcSEcCtD
Clopidogrel—Pancytopenia—Etoposide—brain cancer	0.000281	0.00214	CcSEcCtD
Clopidogrel—Erythema multiforme—Temozolomide—brain cancer	0.00028	0.00213	CcSEcCtD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.00028	0.00469	CbGpPWpGaD
Clopidogrel—CES1—Fluoropyrimidine Activity—TP53—brain cancer	0.000279	0.00469	CbGpPWpGaD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000279	0.00212	CcSEcCtD
Clopidogrel—Neutropenia—Etoposide—brain cancer	0.000277	0.0021	CcSEcCtD
Clopidogrel—Eye disorder—Temozolomide—brain cancer	0.000276	0.0021	CcSEcCtD
Clopidogrel—Urticaria—Procarbazine—brain cancer	0.000276	0.0021	CcSEcCtD
Clopidogrel—Tinnitus—Temozolomide—brain cancer	0.000276	0.0021	CcSEcCtD
Clopidogrel—Abdominal pain—Procarbazine—brain cancer	0.000275	0.00209	CcSEcCtD
Clopidogrel—Body temperature increased—Procarbazine—brain cancer	0.000275	0.00209	CcSEcCtD
Clopidogrel—Oedema—Hydroxyurea—brain cancer	0.000269	0.00205	CcSEcCtD
Clopidogrel—Angiopathy—Temozolomide—brain cancer	0.000268	0.00204	CcSEcCtD
Clopidogrel—Mental disorder—Carmustine—brain cancer	0.000268	0.00204	CcSEcCtD
Clopidogrel—Infection—Hydroxyurea—brain cancer	0.000267	0.00203	CcSEcCtD
Clopidogrel—Immune system disorder—Temozolomide—brain cancer	0.000267	0.00203	CcSEcCtD
Clopidogrel—Mediastinal disorder—Temozolomide—brain cancer	0.000267	0.00203	CcSEcCtD
Clopidogrel—Malnutrition—Carmustine—brain cancer	0.000267	0.00203	CcSEcCtD
Clopidogrel—CES1—E2F transcription factor network—CDKN2A—brain cancer	0.000266	0.00447	CbGpPWpGaD
Clopidogrel—Pneumonia—Etoposide—brain cancer	0.000265	0.00202	CcSEcCtD
Clopidogrel—Nervous system disorder—Hydroxyurea—brain cancer	0.000264	0.00201	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000261	0.00199	CcSEcCtD
Clopidogrel—Skin disorder—Hydroxyurea—brain cancer	0.000261	0.00199	CcSEcCtD
Clopidogrel—Renal failure—Etoposide—brain cancer	0.000259	0.00197	CcSEcCtD
Clopidogrel—Mental disorder—Temozolomide—brain cancer	0.000259	0.00197	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Etoposide—brain cancer	0.000259	0.00197	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—OR4C12—brain cancer	0.000258	0.00434	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—OR14C36—brain cancer	0.000258	0.00434	CbGpPWpGaD
Clopidogrel—Back pain—Carmustine—brain cancer	0.000258	0.00196	CcSEcCtD
Clopidogrel—Malnutrition—Temozolomide—brain cancer	0.000258	0.00196	CcSEcCtD
Clopidogrel—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000257	0.00431	CbGpPWpGaD
Clopidogrel—Stomatitis—Etoposide—brain cancer	0.000257	0.00196	CcSEcCtD
Clopidogrel—Hypersensitivity—Procarbazine—brain cancer	0.000256	0.00195	CcSEcCtD
Clopidogrel—Asthenia—Procarbazine—brain cancer	0.000249	0.0019	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Etoposide—brain cancer	0.000249	0.0019	CcSEcCtD
Clopidogrel—Back pain—Temozolomide—brain cancer	0.000249	0.00189	CcSEcCtD
Clopidogrel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000247	0.00415	CbGpPWpGaD
Clopidogrel—Anaemia—Carmustine—brain cancer	0.000246	0.00187	CcSEcCtD
Clopidogrel—Agranulocytosis—Etoposide—brain cancer	0.000246	0.00187	CcSEcCtD
Clopidogrel—Pruritus—Procarbazine—brain cancer	0.000246	0.00187	CcSEcCtD
Clopidogrel—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000244	0.00409	CbGpPWpGaD
Clopidogrel—Dyspnoea—Hydroxyurea—brain cancer	0.00024	0.00182	CcSEcCtD
Clopidogrel—Leukopenia—Carmustine—brain cancer	0.000239	0.00181	CcSEcCtD
Clopidogrel—Anaemia—Temozolomide—brain cancer	0.000238	0.00181	CcSEcCtD
Clopidogrel—Diarrhoea—Procarbazine—brain cancer	0.000238	0.00181	CcSEcCtD
Clopidogrel—Dyspepsia—Hydroxyurea—brain cancer	0.000237	0.0018	CcSEcCtD
Clopidogrel—Hypoaesthesia—Etoposide—brain cancer	0.000236	0.00179	CcSEcCtD
Clopidogrel—Angioedema—Temozolomide—brain cancer	0.000235	0.00179	CcSEcCtD
Clopidogrel—Urinary tract disorder—Etoposide—brain cancer	0.000234	0.00178	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000232	0.00177	CcSEcCtD
Clopidogrel—Urethral disorder—Etoposide—brain cancer	0.000232	0.00176	CcSEcCtD
Clopidogrel—Fatigue—Hydroxyurea—brain cancer	0.000232	0.00176	CcSEcCtD
Clopidogrel—Vertigo—Temozolomide—brain cancer	0.000231	0.00176	CcSEcCtD
Clopidogrel—Leukopenia—Temozolomide—brain cancer	0.000231	0.00175	CcSEcCtD
Clopidogrel—Hypertension—Carmustine—brain cancer	0.00023	0.00175	CcSEcCtD
Clopidogrel—Constipation—Hydroxyurea—brain cancer	0.00023	0.00175	CcSEcCtD
Clopidogrel—Pain—Hydroxyurea—brain cancer	0.00023	0.00175	CcSEcCtD
Clopidogrel—Dizziness—Procarbazine—brain cancer	0.00023	0.00175	CcSEcCtD
Clopidogrel—Palpitations—Temozolomide—brain cancer	0.000228	0.00173	CcSEcCtD
Clopidogrel—Myalgia—Carmustine—brain cancer	0.000227	0.00173	CcSEcCtD
Clopidogrel—Chest pain—Carmustine—brain cancer	0.000227	0.00173	CcSEcCtD
Clopidogrel—Anxiety—Carmustine—brain cancer	0.000226	0.00172	CcSEcCtD
Clopidogrel—Cough—Temozolomide—brain cancer	0.000225	0.00171	CcSEcCtD
Clopidogrel—Erythema multiforme—Etoposide—brain cancer	0.000224	0.0017	CcSEcCtD
Clopidogrel—Hypertension—Temozolomide—brain cancer	0.000222	0.00169	CcSEcCtD
Clopidogrel—Feeling abnormal—Hydroxyurea—brain cancer	0.000222	0.00169	CcSEcCtD
Clopidogrel—Eye disorder—Etoposide—brain cancer	0.000221	0.00168	CcSEcCtD
Clopidogrel—Vomiting—Procarbazine—brain cancer	0.000221	0.00168	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—BSG—brain cancer	0.00022	0.00369	CbGpPWpGaD
Clopidogrel—Confusional state—Carmustine—brain cancer	0.000219	0.00167	CcSEcCtD
Clopidogrel—Arthralgia—Temozolomide—brain cancer	0.000219	0.00167	CcSEcCtD
Clopidogrel—Myalgia—Temozolomide—brain cancer	0.000219	0.00167	CcSEcCtD
Clopidogrel—Rash—Procarbazine—brain cancer	0.000219	0.00167	CcSEcCtD
Clopidogrel—Dermatitis—Procarbazine—brain cancer	0.000219	0.00167	CcSEcCtD
Clopidogrel—Anxiety—Temozolomide—brain cancer	0.000219	0.00166	CcSEcCtD
Clopidogrel—Headache—Procarbazine—brain cancer	0.000218	0.00166	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000218	0.00166	CcSEcCtD
Clopidogrel—Oedema—Carmustine—brain cancer	0.000218	0.00165	CcSEcCtD
Clopidogrel—Infection—Carmustine—brain cancer	0.000216	0.00164	CcSEcCtD
Clopidogrel—Angiopathy—Etoposide—brain cancer	0.000215	0.00163	CcSEcCtD
Clopidogrel—Immune system disorder—Etoposide—brain cancer	0.000214	0.00163	CcSEcCtD
Clopidogrel—Mediastinal disorder—Etoposide—brain cancer	0.000213	0.00162	CcSEcCtD
Clopidogrel—Body temperature increased—Hydroxyurea—brain cancer	0.000213	0.00162	CcSEcCtD
Clopidogrel—Confusional state—Temozolomide—brain cancer	0.000212	0.00161	CcSEcCtD
Clopidogrel—Anaphylactic shock—Temozolomide—brain cancer	0.00021	0.0016	CcSEcCtD
Clopidogrel—Oedema—Temozolomide—brain cancer	0.00021	0.0016	CcSEcCtD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000209	0.00351	CbGpPWpGaD
Clopidogrel—Infection—Temozolomide—brain cancer	0.000209	0.00159	CcSEcCtD
Clopidogrel—Nausea—Procarbazine—brain cancer	0.000206	0.00157	CcSEcCtD
Clopidogrel—Nervous system disorder—Temozolomide—brain cancer	0.000206	0.00157	CcSEcCtD
Clopidogrel—Skin disorder—Temozolomide—brain cancer	0.000204	0.00155	CcSEcCtD
Clopidogrel—Hypotension—Carmustine—brain cancer	0.000203	0.00155	CcSEcCtD
Clopidogrel—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0002	0.00336	CbGpPWpGaD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000199	0.00335	CbGpPWpGaD
Clopidogrel—Back pain—Etoposide—brain cancer	0.000199	0.00152	CcSEcCtD
Clopidogrel—Hypersensitivity—Hydroxyurea—brain cancer	0.000198	0.00151	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Carmustine—brain cancer	0.000198	0.00151	CcSEcCtD
Clopidogrel—Muscle spasms—Etoposide—brain cancer	0.000198	0.00151	CcSEcCtD
Clopidogrel—Insomnia—Carmustine—brain cancer	0.000197	0.0015	CcSEcCtD
Clopidogrel—Paraesthesia—Carmustine—brain cancer	0.000195	0.00149	CcSEcCtD
Clopidogrel—Dyspnoea—Carmustine—brain cancer	0.000194	0.00147	CcSEcCtD
Clopidogrel—Asthenia—Hydroxyurea—brain cancer	0.000193	0.00147	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000191	0.00146	CcSEcCtD
Clopidogrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000191	0.0032	CbGpPWpGaD
Clopidogrel—Anaemia—Etoposide—brain cancer	0.00019	0.00145	CcSEcCtD
Clopidogrel—Insomnia—Temozolomide—brain cancer	0.00019	0.00145	CcSEcCtD
Clopidogrel—Paraesthesia—Temozolomide—brain cancer	0.000189	0.00144	CcSEcCtD
Clopidogrel—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000188	0.00316	CbGpPWpGaD
Clopidogrel—Gastrointestinal disorder—Carmustine—brain cancer	0.000188	0.00143	CcSEcCtD
Clopidogrel—Dyspnoea—Temozolomide—brain cancer	0.000187	0.00143	CcSEcCtD
Clopidogrel—Constipation—Carmustine—brain cancer	0.000186	0.00141	CcSEcCtD
Clopidogrel—Pain—Carmustine—brain cancer	0.000186	0.00141	CcSEcCtD
Clopidogrel—Vertigo—Etoposide—brain cancer	0.000185	0.00141	CcSEcCtD
Clopidogrel—Dyspepsia—Temozolomide—brain cancer	0.000185	0.00141	CcSEcCtD
Clopidogrel—Leukopenia—Etoposide—brain cancer	0.000184	0.0014	CcSEcCtD
Clopidogrel—Diarrhoea—Hydroxyurea—brain cancer	0.000184	0.0014	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Temozolomide—brain cancer	0.000181	0.00138	CcSEcCtD
Clopidogrel—Fatigue—Temozolomide—brain cancer	0.000181	0.00138	CcSEcCtD
Clopidogrel—Loss of consciousness—Etoposide—brain cancer	0.000181	0.00138	CcSEcCtD
Clopidogrel—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000181	0.00303	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—MYC—brain cancer	0.00018	0.00303	CbGpPWpGaD
Clopidogrel—Cough—Etoposide—brain cancer	0.00018	0.00137	CcSEcCtD
Clopidogrel—Pain—Temozolomide—brain cancer	0.00018	0.00137	CcSEcCtD
Clopidogrel—Constipation—Temozolomide—brain cancer	0.00018	0.00137	CcSEcCtD
Clopidogrel—Feeling abnormal—Carmustine—brain cancer	0.000179	0.00136	CcSEcCtD
Clopidogrel—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000178	0.00299	CbGpPWpGaD
Clopidogrel—Hypertension—Etoposide—brain cancer	0.000178	0.00135	CcSEcCtD
Clopidogrel—Dizziness—Hydroxyurea—brain cancer	0.000178	0.00135	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Carmustine—brain cancer	0.000178	0.00135	CcSEcCtD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000178	0.00298	CbGpPWpGaD
Clopidogrel—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000177	0.00296	CbGpPWpGaD
Clopidogrel—Chest pain—Etoposide—brain cancer	0.000175	0.00133	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000174	0.00133	CcSEcCtD
Clopidogrel—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000174	0.00292	CbGpPWpGaD
Clopidogrel—Feeling abnormal—Temozolomide—brain cancer	0.000173	0.00132	CcSEcCtD
Clopidogrel—Body temperature increased—Carmustine—brain cancer	0.000172	0.00131	CcSEcCtD
Clopidogrel—Abdominal pain—Carmustine—brain cancer	0.000172	0.00131	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Temozolomide—brain cancer	0.000172	0.00131	CcSEcCtD
Clopidogrel—Vomiting—Hydroxyurea—brain cancer	0.000171	0.0013	CcSEcCtD
Clopidogrel—Rash—Hydroxyurea—brain cancer	0.00017	0.00129	CcSEcCtD
Clopidogrel—Confusional state—Etoposide—brain cancer	0.00017	0.00129	CcSEcCtD
Clopidogrel—Dermatitis—Hydroxyurea—brain cancer	0.000169	0.00129	CcSEcCtD
Clopidogrel—Headache—Hydroxyurea—brain cancer	0.000169	0.00128	CcSEcCtD
Clopidogrel—Anaphylactic shock—Etoposide—brain cancer	0.000168	0.00128	CcSEcCtD
Clopidogrel—Infection—Etoposide—brain cancer	0.000167	0.00127	CcSEcCtD
Clopidogrel—P2RY12—GPCR ligand binding—SHH—brain cancer	0.000167	0.0028	CbGpPWpGaD
Clopidogrel—Urticaria—Temozolomide—brain cancer	0.000167	0.00127	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—PTCH2—brain cancer	0.000166	0.00279	CbGpPWpGaD
Clopidogrel—Body temperature increased—Temozolomide—brain cancer	0.000166	0.00126	CcSEcCtD
Clopidogrel—Abdominal pain—Temozolomide—brain cancer	0.000166	0.00126	CcSEcCtD
Clopidogrel—Skin disorder—Etoposide—brain cancer	0.000163	0.00124	CcSEcCtD
Clopidogrel—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000162	0.00272	CbGpPWpGaD
Clopidogrel—Hypersensitivity—Carmustine—brain cancer	0.00016	0.00122	CcSEcCtD
Clopidogrel—Nausea—Hydroxyurea—brain cancer	0.00016	0.00122	CcSEcCtD
Clopidogrel—P2RY12—GPCR ligand binding—SMO—brain cancer	0.000158	0.00266	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—PTCH1—brain cancer	0.000158	0.00266	CbGpPWpGaD
Clopidogrel—Hypotension—Etoposide—brain cancer	0.000157	0.0012	CcSEcCtD
Clopidogrel—Asthenia—Carmustine—brain cancer	0.000156	0.00119	CcSEcCtD
Clopidogrel—Hypersensitivity—Temozolomide—brain cancer	0.000155	0.00118	CcSEcCtD
Clopidogrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000155	0.00259	CbGpPWpGaD
Clopidogrel—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000153	0.00257	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—OR14C36—brain cancer	0.000153	0.00256	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—OR4C12—brain cancer	0.000153	0.00256	CbGpPWpGaD
Clopidogrel—Paraesthesia—Etoposide—brain cancer	0.000151	0.00115	CcSEcCtD
Clopidogrel—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000151	0.00253	CbGpPWpGaD
Clopidogrel—Asthenia—Temozolomide—brain cancer	0.000151	0.00115	CcSEcCtD
Clopidogrel—Dyspnoea—Etoposide—brain cancer	0.00015	0.00114	CcSEcCtD
Clopidogrel—Diarrhoea—Carmustine—brain cancer	0.000149	0.00113	CcSEcCtD
Clopidogrel—Pruritus—Temozolomide—brain cancer	0.000149	0.00113	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Etoposide—brain cancer	0.000145	0.0011	CcSEcCtD
Clopidogrel—Fatigue—Etoposide—brain cancer	0.000145	0.0011	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—TRPC6—brain cancer	0.000144	0.00242	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—ABR—brain cancer	0.000144	0.00241	CbGpPWpGaD
Clopidogrel—Dizziness—Carmustine—brain cancer	0.000144	0.00109	CcSEcCtD
Clopidogrel—Constipation—Etoposide—brain cancer	0.000144	0.00109	CcSEcCtD
Clopidogrel—Pain—Etoposide—brain cancer	0.000144	0.00109	CcSEcCtD
Clopidogrel—Diarrhoea—Temozolomide—brain cancer	0.000144	0.00109	CcSEcCtD
Clopidogrel—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000144	0.00241	CbGpPWpGaD
Clopidogrel—Dizziness—Temozolomide—brain cancer	0.000139	0.00106	CcSEcCtD
Clopidogrel—Feeling abnormal—Etoposide—brain cancer	0.000139	0.00105	CcSEcCtD
Clopidogrel—Vomiting—Carmustine—brain cancer	0.000138	0.00105	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Etoposide—brain cancer	0.000138	0.00105	CcSEcCtD
Clopidogrel—Rash—Carmustine—brain cancer	0.000137	0.00104	CcSEcCtD
Clopidogrel—Dermatitis—Carmustine—brain cancer	0.000137	0.00104	CcSEcCtD
Clopidogrel—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000137	0.00229	CbGpPWpGaD
Clopidogrel—Headache—Carmustine—brain cancer	0.000136	0.00104	CcSEcCtD
Clopidogrel—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000135	0.00226	CbGpPWpGaD
Clopidogrel—Vomiting—Temozolomide—brain cancer	0.000134	0.00102	CcSEcCtD
Clopidogrel—Urticaria—Etoposide—brain cancer	0.000134	0.00102	CcSEcCtD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000133	0.00223	CbGpPWpGaD
Clopidogrel—Body temperature increased—Etoposide—brain cancer	0.000133	0.00101	CcSEcCtD
Clopidogrel—Abdominal pain—Etoposide—brain cancer	0.000133	0.00101	CcSEcCtD
Clopidogrel—Rash—Temozolomide—brain cancer	0.000133	0.00101	CcSEcCtD
Clopidogrel—Dermatitis—Temozolomide—brain cancer	0.000132	0.00101	CcSEcCtD
Clopidogrel—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000132	0.00221	CbGpPWpGaD
Clopidogrel—Headache—Temozolomide—brain cancer	0.000132	0.001	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—ABR—brain cancer	0.000131	0.00219	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—DTX2—brain cancer	0.00013	0.00218	CbGpPWpGaD
Clopidogrel—Nausea—Carmustine—brain cancer	0.000129	0.000983	CcSEcCtD
Clopidogrel—Nausea—Temozolomide—brain cancer	0.000125	0.00095	CcSEcCtD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000124	0.00209	CbGpPWpGaD
Clopidogrel—Hypersensitivity—Etoposide—brain cancer	0.000124	0.000942	CcSEcCtD
Clopidogrel—Asthenia—Etoposide—brain cancer	0.000121	0.000918	CcSEcCtD
Clopidogrel—Pruritus—Etoposide—brain cancer	0.000119	0.000905	CcSEcCtD
Clopidogrel—Diarrhoea—Etoposide—brain cancer	0.000115	0.000875	CcSEcCtD
Clopidogrel—Dizziness—Etoposide—brain cancer	0.000111	0.000846	CcSEcCtD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00011	0.00184	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—VAV1—brain cancer	0.000108	0.00181	CbGpPWpGaD
Clopidogrel—Vomiting—Etoposide—brain cancer	0.000107	0.000813	CcSEcCtD
Clopidogrel—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000106	0.00179	CbGpPWpGaD
Clopidogrel—Rash—Etoposide—brain cancer	0.000106	0.000807	CcSEcCtD
Clopidogrel—Dermatitis—Etoposide—brain cancer	0.000106	0.000806	CcSEcCtD
Clopidogrel—Headache—Etoposide—brain cancer	0.000105	0.000801	CcSEcCtD
Clopidogrel—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000105	0.00176	CbGpPWpGaD
Clopidogrel—Nausea—Etoposide—brain cancer	9.99e-05	0.00076	CcSEcCtD
Clopidogrel—P2RY12—Signaling Pathways—PTCH2—brain cancer	9.83e-05	0.00165	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HES5—brain cancer	9.52e-05	0.0016	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—IL2—brain cancer	9.36e-05	0.00157	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—STRADA—brain cancer	9.24e-05	0.00155	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—TRPC6—brain cancer	9.11e-05	0.00153	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—SHH—brain cancer	8.57e-05	0.00144	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—PDGFRA—brain cancer	8.49e-05	0.00143	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—TRPC6—brain cancer	8.27e-05	0.00139	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.21e-05	0.00138	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PTCH1—brain cancer	8.13e-05	0.00136	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—SMO—brain cancer	8.13e-05	0.00136	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	8.1e-05	0.00136	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—VEGFA—brain cancer	7.95e-05	0.00133	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ABR—brain cancer	7.72e-05	0.00129	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GLI2—brain cancer	7.45e-05	0.00125	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	7.08e-05	0.00119	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GLI1—brain cancer	7.01e-05	0.00118	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—PIK3CG—brain cancer	6.85e-05	0.00115	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—VAV1—brain cancer	6.82e-05	0.00114	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	6.72e-05	0.00113	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SUFU—brain cancer	6.64e-05	0.00111	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GFAP—brain cancer	6.41e-05	0.00108	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.33e-05	0.00106	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—VAV1—brain cancer	6.19e-05	0.00104	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HEY1—brain cancer	6.07e-05	0.00102	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—DLL1—brain cancer	5.96e-05	0.001	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.88e-05	0.000986	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	5.87e-05	0.000986	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.7e-05	0.000957	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.67e-05	0.000951	CbGpPWpGaD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	5.31e-05	0.000891	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.24e-05	0.00088	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SHH—brain cancer	5.07e-05	0.00085	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TRPC6—brain cancer	4.88e-05	0.00082	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.85e-05	0.000813	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—IL2—brain cancer	4.82e-05	0.000809	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PTCH1—brain cancer	4.8e-05	0.000806	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SMO—brain cancer	4.8e-05	0.000806	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.66e-05	0.000781	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—IL2—brain cancer	4.63e-05	0.000778	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.57e-05	0.000766	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	4.55e-05	0.000763	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.51e-05	0.000757	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.46e-05	0.000748	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.36e-05	0.000732	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.36e-05	0.000732	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—PIK3CG—brain cancer	4.33e-05	0.000727	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.3e-05	0.000721	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	4.19e-05	0.000703	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—VEGFA—brain cancer	4.1e-05	0.000688	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.09e-05	0.000686	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.99e-05	0.00067	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.94e-05	0.000661	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PIK3CG—brain cancer	3.93e-05	0.00066	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NOTCH2—brain cancer	3.84e-05	0.000644	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.83e-05	0.000644	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VAV1—brain cancer	3.66e-05	0.000614	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.5e-05	0.000587	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.45e-05	0.000579	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.25e-05	0.000545	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HES1—brain cancer	3.15e-05	0.000528	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TP53—brain cancer	3.1e-05	0.00052	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP2C9—brain cancer	3.09e-05	0.000519	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—IL2—brain cancer	3.05e-05	0.000512	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP2C9—brain cancer	3.02e-05	0.000507	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PDGFRA—brain cancer	3e-05	0.000503	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.99e-05	0.000501	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SPP1—brain cancer	2.91e-05	0.000488	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL2—brain cancer	2.77e-05	0.000465	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.71e-05	0.000455	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IRS2—brain cancer	2.63e-05	0.000442	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—BSG—brain cancer	2.63e-05	0.000441	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP2C9—brain cancer	2.62e-05	0.000439	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—BSG—brain cancer	2.57e-05	0.000431	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.52e-05	0.000424	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP2C9—brain cancer	2.34e-05	0.000392	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CG—brain cancer	2.32e-05	0.00039	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—APC—brain cancer	2.32e-05	0.00039	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP2C9—brain cancer	2.28e-05	0.000383	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—IDH1—brain cancer	2.26e-05	0.000379	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.23e-05	0.000374	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—BSG—brain cancer	2.22e-05	0.000373	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—IDH1—brain cancer	2.21e-05	0.000371	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.21e-05	0.000371	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—EGFR—brain cancer	2.12e-05	0.000355	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—BSG—brain cancer	1.99e-05	0.000333	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.94e-05	0.000326	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—BSG—brain cancer	1.94e-05	0.000325	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—IDH1—brain cancer	1.91e-05	0.000321	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP2C9—brain cancer	1.82e-05	0.000305	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—RELA—brain cancer	1.82e-05	0.000305	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—BSG—brain cancer	1.81e-05	0.000304	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ERBB2—brain cancer	1.8e-05	0.000303	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.79e-05	0.0003	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ENO2—brain cancer	1.79e-05	0.0003	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.75e-05	0.000294	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ENO2—brain cancer	1.75e-05	0.000293	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—IDH1—brain cancer	1.71e-05	0.000287	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—IDH1—brain cancer	1.67e-05	0.00028	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL2—brain cancer	1.64e-05	0.000274	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCND1—brain cancer	1.59e-05	0.000268	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CTNNB1—brain cancer	1.58e-05	0.000265	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.56e-05	0.000261	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—IDH1—brain cancer	1.56e-05	0.000261	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—BSG—brain cancer	1.55e-05	0.00026	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ENO2—brain cancer	1.51e-05	0.000254	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.47e-05	0.000246	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP2C9—brain cancer	1.4e-05	0.000236	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.39e-05	0.000233	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VEGFA—brain cancer	1.39e-05	0.000233	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—STAT3—brain cancer	1.38e-05	0.000231	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ENO2—brain cancer	1.35e-05	0.000227	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—IDH1—brain cancer	1.33e-05	0.000223	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ENO2—brain cancer	1.32e-05	0.000221	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—brain cancer	1.28e-05	0.000215	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.27e-05	0.000213	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EGFR—brain cancer	1.25e-05	0.00021	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ENO2—brain cancer	1.23e-05	0.000207	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—BSG—brain cancer	1.19e-05	0.0002	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.08e-05	0.000182	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ENO2—brain cancer	1.05e-05	0.000177	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—brain cancer	1.05e-05	0.000176	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—IDH1—brain cancer	1.03e-05	0.000172	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CG—brain cancer	8.19e-06	0.000138	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ENO2—brain cancer	8.12e-06	0.000136	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CG—brain cancer	8.01e-06	0.000134	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CG—brain cancer	6.94e-06	0.000116	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CG—brain cancer	6.19e-06	0.000104	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CG—brain cancer	6.04e-06	0.000101	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CG—brain cancer	5.65e-06	9.48e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CG—brain cancer	4.82e-06	8.1e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CG—brain cancer	3.72e-06	6.25e-05	CbGpPWpGaD
